The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of Cannabinoids In The Treatment Of Epilepsy - EP3206716

The patent EP3206716 was granted to GW Pharma on Jul 29, 2020. The application was filed on Oct 14, 2015 under application number EP15784111A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3206716

GW PHARMA
Application Number
EP15784111A
Filing Date
Oct 14, 2015
Status
Granted And Under Opposition
Jun 26, 2020
Publication Date
Jul 29, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JAMES POOLEApr 29, 2021CABINET BECKER ET ASSOCIESWITHDRAWN

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2008094181
INTERNATIONAL-SEARCH-REPORTWO2012093255
INTERNATIONAL-SEARCH-REPORTWO2015193668
OPPOSITIONEP3157512
OPPOSITIONWO2008094181
OPPOSITIONWO2012093255
OPPOSITIONWO2015193668

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents